Genmab A (GMAB) Asset Utilization Ratio (2024 - 2026)

Genmab A (GMAB) posted Asset Utilization Ratio of 0.47 for Q1 2026, down 56.23% on a QoQ basis from 1.07 in Q3 2025, and down 37.84% year-over-year from 0.75 in Q1 2025.

Genmab A (GMAB) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Genmab A's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.47 for Q1 2026.

  • Quarterly Asset Utilization Ratio fell 37.84% year-over-year to 0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.47 (down 37.84% YoY) and the FY2025 annual result came in at 0.38, changed N/A from the prior year.
  • Asset Utilization Ratio was 0.47 for Q1 2026 at Genmab A, down from 1.07 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 114666058064.52 in Q3 2024 and bottomed at 0.47 in Q1 2026.
  • A 3-year average of 22933211613.54 and a median of 0.91 in 2025 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2025 — Asset Utilization Ratio sank 100.0% — and 2026, when it plunged 37.84%.
  • Genmab A's Asset Utilization Ratio stood at 114666058064.52 in 2024, then plunged by 100.0% to 1.07 in 2025, then tumbled by 56.23% to 0.47 in 2026.
  • Business Quant data shows GMAB's Asset Utilization Ratio at 0.47 in Q1 2026, 1.07 in Q3 2025, and 0.91 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Genmab A 1.89 Bn 366.92 Mn 831.00 Mn 0.47

Historic Data

Download Data
DateValue
Mar 31, 2026 0.47
Sep 30, 2025 1.07
Jun 30, 2025 0.91
Mar 31, 2025 0.75
Sep 30, 2024 114.67 Bn